What does CUSIP 68235C107 represent in this 13F holders report?

CUSIP 68235C107 is the security identifier for OCX - Oncocyte Corporation - Common Shares, No Par Value used to aggregate holder disclosures.

How many institutions held OCX - Oncocyte Corporation - Common Shares, No Par Value in Q2 2019?

48 institutional investors reported OCX - Oncocyte Corporation - Common Shares, No Par Value for Q2 2019. Use the holders table for investor-level position and value details.

Oncocyte Corporation - Common Shares, No Par Value (OCX)

CUSIP: 68235C107

Q2 2019 13F Holders as of 30 Jun 2019

Security type / class: Equity / Common Shares, No Par Value
Total 13F shares: 15,958,159
Total 13F value: $39,753,182
Share change: -137,099
SEC-reported price per share: $2.49
Number of holders: 48
Value change: -$2,942,657
Number of buys: 30
Number of sells: 26
Shares outstanding: 28,495,649

Security key

68235C107

Report period

Q2 2019

Institutions

Top holders

OCX full security history Ownership snapshot Full 13F holder table Insight Molecular Diagnostics Inc. SEC filings Insight Molecular Diagnostics Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of OCX - Oncocyte Corporation - Common Shares, No Par Value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

BROADWOOD CAPITAL INC

Disclosed value leader

BROADWOOD CAPITAL INC

Comparable rows

15/15

Latest evidence

31 Mar 2019

13F Lead comparable stake: 28% Showing 1-6 of 15 holder rows.

Quick read

BROADWOOD CAPITAL INC leads the comparable SEC ownership view at 28%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BROADWOOD CAPITAL INC's linked filing trail.

Comparable ownership Top 5

BROADWOOD CAPITAL INC 28%

EMERALD MUTUAL FUND ADVISERS TRUST 8.7%

RTW INVESTMENTS, LP 4.5%

VANGUARD GROUP INC 4.4%

Schonfeld Strategic Advisors LLC 3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
BROADWOOD CAPITAL INC	13F Company 13F	28%	$31,988,000 8,098,267 shares	—	31 Mar 2019
EMERALD MUTUAL FUND ADVISERS TRUST	13F Company 13F	8.7%	$9,836,000 2,490,000 shares	—	31 Mar 2019
RTW INVESTMENTS, LP	13F Company 13F	4.5%	$5,091,000 1,288,873 shares	—	31 Mar 2019
VANGUARD GROUP INC	13F Company 13F	4.4%	$4,967,000 1,257,419 shares	—	31 Mar 2019
Schonfeld Strategic Advisors LLC	13F Company 13F	3%	$3,431,000 868,793 shares	—	31 Mar 2019
Manatuck Hill Partners, LLC	13F Company 13F	0.85%	$961,000 243,400 shares	—	31 Mar 2019

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2019

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

15,958,159

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2019 vs Q1 2019 Across Filers

Q1 2019 holders

Q2 2019 holders

Holder diff

Investor	Q1 2019 Shares	Q2 2019 Shares	Share Diff	Share Chg %	Q1 2019 value	Q2 2019 value	Value change	Value Chg %